Committee hears calls for oversight of youth psychotropic prescriptions and expanded school mental‑health supports

The Health Care committee discussed several youth mental health proposals May 9, including improved reporting and oversight of psychotropic medications for children and expansion of school‑based and peer‑led services.

Members said statewide data flagged a substantial number of children receiving psychotropic medications and asked for better reporting and protections for young patients. A committee member said national monitoring had raised alarms when Vermont’s counts appeared in the data; the member asked the Office of the Health Care Advocate and other agencies to help assemble better reporting and oversight information.

Committee members singled out several bills for summer work: a short‑form bill (H.305) to increase oversight of psychotropic prescriptions in children and adolescents, and another proposal (listed in committee materials) to fund school‑based mental health programs and peer support through a mental health innovation special fund. Members described school‑based peer programs and trainings (for example, NAMI trainings) as potentially scalable elements to improve early intervention.

Members asked staff to line up testimony from the Office of the Health Care Advocate, clinicians, school representatives and youth‑focused advocates to clarify numbers, guardianship and consent issues, and potential reporting requirements. No committee action was taken at the meeting.